3SBio Inc. (SSRX) Tops Q2 EPS by 5c

3SBio Inc. (NASDAQ: SSRX) reported Q2 EPS of $0.29, $0.05 better than the analyst estimate of $0.24. Revenue for the quarter came in at $28.1 million versus the consensus estimate of $25.88 million.

For earnings history and earnings-related data on 3SBio Inc. (SSRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c